J&J Recalls Neutrogena Light Therapy Acne Mask On Reports Of Eye Injuries
According to the J&J brand, a small subset of users with underlying eye conditions are potentially at risk of being injured by the FDA-cleared device, which uses red and blue LEDs to combat bacteria and inflammation associated with acne.
You may also be interested in...
Company leadership has said that Vogue International – the maker of OGX and Maui Moisture hair care that J&J acquired in 2016 – would serve as a model for innovations across other brands. Strategy appears to be paying off, contributing to gains in J&J's Consumer division, which also benefited in the second quarter from Zyrtec allergy treatment and children’s Tylenol and Motrin.
The Capillus82 Hair Regrowth Laser Cap may be "substantially equivalent" to the manufacturer's Capillus272 Pro device, based on FDA's 510(k) clearance, but NAD says hair-growth clinical findings from that "predicate" device cannot serve to substantiate claims for the untested Capillus82. The case illustrates complexities in the medical device segment, which increasingly is of interest to cosmetics companies.
During an investor day conference held May 18, Johnson & Johnson execs discussed the firm's consumer business at length, offering a preview of dynamic new launches planned for the year.